William B. Feldman

1.5k total citations
79 papers, 623 citations indexed

About

William B. Feldman is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, William B. Feldman has authored 79 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Economics and Econometrics, 18 papers in Pulmonary and Respiratory Medicine and 17 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in William B. Feldman's work include Pharmaceutical Economics and Policy (28 papers), Health Systems, Economic Evaluations, Quality of Life (25 papers) and Pharmaceutical studies and practices (16 papers). William B. Feldman is often cited by papers focused on Pharmaceutical Economics and Policy (28 papers), Health Systems, Economic Evaluations, Quality of Life (25 papers) and Pharmaceutical studies and practices (16 papers). William B. Feldman collaborates with scholars based in United States, Canada and United Kingdom. William B. Feldman's co-authors include Aaron S. Kesselheim, Benjamin N. Rome, S. Sean Tu, Reed F. Beall, Michael Safaee, Christopher P. Ames, Andrew T. Parsa, Aaron J. Clark, Spencer Phillips Hey and Jerry Avorn and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

William B. Feldman

70 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William B. Feldman United States 14 237 83 80 74 71 79 623
Tim A. Kanters Netherlands 17 202 0.9× 84 1.0× 38 0.5× 58 0.8× 47 0.7× 43 675
K Malottki United Kingdom 11 124 0.5× 50 0.6× 86 1.1× 238 3.2× 59 0.8× 17 725
Sanjeev Balu United States 15 136 0.6× 76 0.9× 39 0.5× 87 1.2× 144 2.0× 48 988
Xiaoyun Pan United States 14 128 0.5× 37 0.4× 206 2.6× 36 0.5× 151 2.1× 41 671
Liza Takiya United States 15 86 0.4× 84 1.0× 22 0.3× 85 1.1× 51 0.7× 47 888
Geert Frederix Netherlands 16 67 0.3× 52 0.6× 128 1.6× 95 1.3× 78 1.1× 61 945
Jörg Ruof Germany 21 401 1.7× 85 1.0× 46 0.6× 197 2.7× 39 0.5× 67 1.4k
W. Clark United Kingdom 10 107 0.5× 32 0.4× 37 0.5× 142 1.9× 33 0.5× 15 741
Louise Crathorne United Kingdom 14 130 0.5× 25 0.3× 90 1.1× 24 0.3× 160 2.3× 33 559
Bruno Horisberger Switzerland 14 245 1.0× 61 0.7× 31 0.4× 51 0.7× 109 1.5× 36 955

Countries citing papers authored by William B. Feldman

Since Specialization
Citations

This map shows the geographic impact of William B. Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William B. Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William B. Feldman more than expected).

Fields of papers citing papers by William B. Feldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William B. Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William B. Feldman. The network helps show where William B. Feldman may publish in the future.

Co-authorship network of co-authors of William B. Feldman

This figure shows the co-authorship network connecting the top 25 collaborators of William B. Feldman. A scholar is included among the top collaborators of William B. Feldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William B. Feldman. William B. Feldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feldman, William B., et al.. (2025). The Moral Injury of Inhaler Prescribing. New England Journal of Medicine. 392(9). 836–839. 4 indexed citations
2.
Tu, S. Sean & William B. Feldman. (2024). Use of Track One Prioritized Examination for Pharmaceutical Patents. JAMA Health Forum. 5(7). e241886–e241886. 1 indexed citations
3.
Wang, Junyi, et al.. (2024). Commercial markups on pediatric oncology drugs at 340B pediatric hospitals. Pediatric Blood & Cancer. 71(9). e31158–e31158. 1 indexed citations
4.
Feldman, William B., Leah Z. Rand, Daniel Carpenter, et al.. (2024). Trust in the Food and Drug Administration: A National Survey Study. Clinical Pharmacology & Therapeutics. 116(2). 408–414. 3 indexed citations
5.
Feldman, William B., Samy Suissa, Aaron S. Kesselheim, et al.. (2024). Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease: new user cohort study. BMJ. 387. e080409–e080409. 10 indexed citations
6.
Kesselheim, Aaron S., et al.. (2024). National Survey of Factors Associated with Physician Antibiotic Prescribing Preferences. Journal of General Internal Medicine. 40(4). 838–846.
7.
Hernandez, Inmaculada, et al.. (2024). Price and Variability in Hospital Charges for Generic Indomethacin Suppositories. JAMA Network Open. 7(9). e2435528–e2435528. 1 indexed citations
8.
Kesselheim, Aaron S., et al.. (2024). Delivery Device Patents on GLP-1 Receptor Agonists. JAMA. 331(9). 794–794.
9.
Tu, S. Sean, Rachel W. Goode, & William B. Feldman. (2023). Biologic Patent Thickets and Terminal Disclaimers. JAMA. 331(4). 355–355. 7 indexed citations
10.
Tu, S. Sean, et al.. (2023). Patenting Strategies on Inhaler Delivery Devices. CHEST Journal. 164(2). 450–460. 5 indexed citations
11.
Beall, Reed F., et al.. (2023). Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986–2019. PLoS Medicine. 20(11). e1004309–e1004309. 7 indexed citations
12.
Cliff, Edward R. Scheffer, Amar H. Kelkar, David A. Russler‐Germain, et al.. (2023). High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions. American Society of Clinical Oncology Educational Book. 43(43). e397912–e397912. 66 indexed citations
13.
Cliff, Edward R. Scheffer, Aaron S. Kesselheim, & William B. Feldman. (2023). Ensuring Ethical Postprogression Therapy for Patients in Randomized Trial Control Arms. Journal of Clinical Oncology. 41(24). 3984–3987. 5 indexed citations
14.
Rand, Leah Z., et al.. (2023). Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines. The Hastings Center Report. 53(S2). S60–S68. 4 indexed citations
15.
Lin, Kueiyu Joshua, William B. Feldman, Shirley Wang, et al.. (2022). Gastrointestinal prophylaxis for COVID-19: an illustration of severe bias arising from inappropriate comparators in observational studies. Journal of Clinical Epidemiology. 151. 45–52. 2 indexed citations
16.
Bharadwaj, Maheetha, Sandeep P. Kishore, Marisa Winkler, et al.. (2021). Empirical Assessment of U.S. Coronavirus Disease 2019 Crisis Standards of Care Guidelines. Critical Care Explorations. 3(7). e0496–e0496. 3 indexed citations
17.
Sarpatwari, Ameet, Katsiaryna Bykov, Jerry Avorn, et al.. (2021). A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs. Drug Safety. 44(7). 743–751. 9 indexed citations
18.
Feldman, William B., Anthony Kim, & Winston Chiong. (2017). Trends in Recruitment Rates for Acute Stroke Trials, 1990–2014. Stroke. 48(3). 799–801. 20 indexed citations
19.
Feldman, William B., Aaron D. Besterman, John‐Paul J. Yu, Jeffrey DeVido, & James A. Bourgeois. (2014). Persistent Perceptual Disturbances After Lithium Toxicity: A Case Report and Discussion. Psychosomatics. 56(3). 306–310. 4 indexed citations
20.
Feldman, William B.. (2005). Theories of Emergency Powers: A Comparative Analysis of American Martial Law and the French State of Siege. Cornell international law journal. 38(3). 1021–1048. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim A. Kanters Breakdown of academic impact, for papers by K Malottki Breakdown of academic impact, for papers by Sanjeev Balu Breakdown of academic impact, for papers by Xiaoyun Pan Breakdown of academic impact, for papers by Liza Takiya Breakdown of academic impact, for papers by Geert Frederix Breakdown of academic impact, for papers by Jörg Ruof Breakdown of academic impact, for papers by W. Clark Breakdown of academic impact, for papers by Louise Crathorne Breakdown of academic impact, for papers by Bruno Horisberger
Rankless by CCL
2026